Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for aging in middle-aged and elderly males
NCT06459310Phase 2Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Jun 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in aging, sponsored by Xuanwu Hospital. Started Jun 2024; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
aging
Beyond the preview
Go deeper on NCT06459310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06459310.